In other words, the entry of biosimilars into a reference product's market does not guarantee patient savings. Benefit design ...
A Milwaukee hospital alleges CVS used its control of a PBM, specialty pharmacy and third-party administrator to reduce ...
"Understanding the financial challenges LGBTQ+ adults face when accessing health care can help identify persistent gaps in ...
Nearly 70% of the estimate rests on payments above an insurer-calculated benchmark that a federal appeals court recently ...
This not only would be the fifth-consecutive year of elevated cost growth but also would be the largest annual increase since ...
UnitedHealth Group's UnitedHealthcare unit has posted a list of procedure codes for about 1,700 procedures that will no ...
A new analysis of disclosures from 10 of the largest brand drugmakers, contained from the Centers for Medicare and Medicaid ...
USI is a Valhalla, New York-based company with 10,500 employees, 200 U.S. offices, about $3.3 billion in total annual revenue and about $1.5 billion in U.S. benefits revenue. It appears to be a bit ...
These agreements bring the total number of pharmaceutical manufacturers with MFN deals to 26, covering nearly 90% of the ...
Regulators in are warning would-be insurance producers against trusting recruiters who seem a little too helpful.
The agency alleged that The Villages Health System, based in the 55-plus community of The Villages in central Florida, submitted false diagnosis codes to increase payments from the Medicare Advantage ...